Smith & Nephew plc ADR Stock
Smith & Nephew plc ADR Stock
A loss of -1.370% shows a downward development for Smith & Nephew plc ADR.
Pros and Cons of Smith & Nephew plc ADR in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Smith & Nephew plc ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Smith & Nephew plc ADR | -1.370% | 2.128% | -2.703% | 21.008% | 22.034% | 12.500% | -14.286% |
| Smith & Nephew plc | 0.840% | 1.444% | -0.928% | 19.197% | 20.797% | 12.101% | -15.587% |
| Dexcom Inc. | 1.770% | 3.884% | 21.839% | -23.433% | -23.483% | -47.767% | -19.203% |
| Veeva Systems A | -2.060% | -5.271% | -23.417% | -16.282% | -3.593% | 19.846% | -10.302% |
Comments
Smith & Nephew SNATS (NYSE:SNN) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Show more
Ratings data for SNN provided by MarketBeat
Smith & Nephew plc (NYSE: SNN) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating on the stock.
Show more
Ratings data for SNN provided by MarketBeat
Smith & Nephew plc (NYSE: SNN) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.
Show more
Ratings data for SNN provided by MarketBeat
